Obesity has become a significant public health problem since it may cause many chronic diseases, including type 2 diabetes, cardiovascular diseases, liver diseases, and some cancers. Recent studies have shown that obesity is a major risk factor for the development of inflammatory skin diseases, including eczema, atopic dermatitis, and psoriasis. Inflammatory cytokines produced from adipose tissue and activation of innate immunity are considered as important factors in obesity-induced inflammation. However, the molecular mechanisms by which obesity affects the development of inflammatory skin diseases are not well understood. In this review, we will discuss the relationship between the underlying mechanisms linking obesity and inflammatory skin diseases based on the latest researches.

obesity; psoriasis; inflammation; adipokine; high fat diet; fatty acids

1. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4(8): 579–591. doi: 10.1038/nrc1408.

2. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288(14): 1723–1727. doi: 10.1001/jama.288.14.1723.

3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289(1): 76–79. doi: 10.1001/jama.289.1.76.

4. Guida B, Nino M, Perrino NR, et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol 2010; 24(2): 191–195. doi: 10.1111/j.1468-3083.2009.03503.x.

5. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56(6): 901–916. doi: 10.1016/j.jaad.2006.12.004.

6. Black MM, Bottoms E, Shuster S. Skin collagen and thickness in simple obesity. Br Med J 1971; 4(5780): 149–150. doi: 10.1136/bmj.4.5780.149.

7. Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol 1994; 1(2): 202–205.

8. Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545–1602. doi: 10.1016/S0140-6736(16)31678-6.

9. Honda T, Egawa G, Grabbe S, et al. Update of immune events in the murine contact hypersensitivity model: Toward the understanding of allergic contact dermatitis. J Invest Dermatol 2013; 133(2): 303–315. doi: 10.1038/jid.2012.284.

10. Griffiths CEM, Barker J, Bleiker T, et al. Rook’s Textbook of Dermatology, 4 Volume Set. 9th ed. West Sussex, UK: John Wiley & Sons; 2016. doi: 10.1002/9781118441213.

11. Silverberg JI, Simpson EL. Association between obesity and eczema prevalence, severity and poorer health in US adolescents. Dermatitis 2014; 25(4): 172–181. doi: 10.1097/DER.0000000000000047.

12. Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 2015; 135(3): 721–728. doi: 10.1016/j.jaci.2014.11.023.

13. Otsuka A, Nomura T, Rerknimitr P, et al. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev 2017; 278(1): 246–262. doi: 10.1111/imr.12545.

14. Honda T, Nomura T, Kabashima K. Advances in atopic dermatitis and urticarial in 2016. J Allergy Clin Immunol 2017; 140(2): 369–376. doi: 10.1016/j.jaci.2017.06.005.

15. Kabashima K. New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013; 70(1): 3–11. doi: 10.1016/j.jdermsci.2013.02.001.

16. Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 2017; 137(1): 18–25. doi: 10.1016/j.jid.2016.08.022.

17. Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: A systematic review and metaanalysis. J Am Acad Dermatol 2015; 72(4): 606–616. doi: 10.1016/j.jaad.2014.12.013.

18. Noda S, Suarez-Farinas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol 2015; 136(5): 1254–1264. doi: 10.1016/j.jaci.2015.08.015.

19. Gudjonsson JE, Elder JT. Psoriasis: Epidemiology. Clin Dermatol 2007; 25(6): 535–546. doi: 10.1016/j.clindermatol.2007.08.007.

20. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies. Nutr Diabetes 2012; 2: e54. doi: 10.1038/nutd.2012.26.

21. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. J Invest Dermatol 2005; 125(1): 61–67. doi: 10.1111/j.0022-202X.2005.23681.x.

22. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med 2007; 167(15): 1670–1675. doi: 10.1001/archinte.167.15.1670.

23. Bardazzi F, Balestri R, Baldi E, et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther 2010; 23(Suppl 1): S14–19. doi: 10.1111/j.1529-8019.2009.01281.x.

24. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29(24): 2959–2971. doi: 10.1093/eurheartj/ehn387.

25. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112(12): 1821–1830. doi: 10.1172/JCI19451.

26. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112(12): 1796–1808. doi: 10.1172/JCI19246.

27. Wang P, Mariman E, Renes J, et al. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008; 216(1): 3–13. doi: 10.1002/jcp.21386.

28. Natsuaki Y, Egawa G, Nakamizo S, et al. Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat Immunol 2014; 15(11): 1064–1069. doi: 10.1038/ni.2992.

29. Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest 2006; 116(8): 2084–2087. doi: 10.1172/JCI29441.

30. Egawa G, Miyachi Y, Kabashima K. Identification of perivascular adipose tissue in the mouse skin using two-photon microscopy. J Dermatol Sci 2013; 70(2): 139–140. doi: 10.1016/j.jdermsci.2013.02.009.

31. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11(8): 327–332. doi: 10.1016/S1043-2760(00)00301-5.

32. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19(4): 972–978. doi: 10.1161/01.ATV.19.4.972.

33. Mirza MS. Obesity, visceral fat, and NAFLD: Querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol 2011; 2011: 592404. doi: 10.5402/2011/592404.

34. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269(5223): 540–543. doi: 10.1126/science.7624776.

35. Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394(6696): 897–901. doi: 10.1038/29795.

36. Cerman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159(4): 820–826. doi: 10.1111/j.1365-2133.2008.08742.x.

37. Stjernholm T, Ommen P, Langkilde A, et al. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes. Exp Dermatol 2017; 26(4): 338–345. doi: 10.1111/exd.13149.

38. Aprahamian TR, Sam F. Adiponectin in cardiovascular inflammation and obesity. Int J Inflam 2011; 2011: 376909. doi: 10.4061/2011/376909.

39. Poeggeler B, Schulz C, Pappolla MA, et al. Leptin and the skin: A new frontier. Exp Dermatol 2010; 19(1): 12–18. doi: 10.1111/j.1600-0625.2009.00930.x.

40. Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24(12): 1386–1394. doi: 10.1111/j.1468-3083.2010.03647.x.

41. Shibata S, Tada Y, Hau CS, et al. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gammadelta-T cells. Nat Commun 2015; 6: 7687. doi: 10.1038/ncomms8687.

42. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272(24): 15258–15263. doi: 10.1074/jbc.272.24.15258.

43. Zhang LJ, Guerrero-Juarez CF, Hata T, et al. Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science 2015; 347(6217): 67–71. doi: 10.1126/science.1260972.

44. Loffler H, Aramaki JU, Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol 2002; 8(1): 19–22. doi: 10.1046/j.0909-752x.

45. Taylor KR, Costanzo AE, Jameson JM. Dysfunctional gammadelta T cells contribute to impaired keratinocyte homeostasis in mouse models of obesity. J Invest Dermatol 2011; 131(12): 2409–2418. doi: 10.1038/jid.2011.241.

46. Gilliland FD, Berhane K, Islam T, et al. Obesity and the risk of newly diagnosed asthma in school-age children. Am J Epidemiol 2003; 158(5): 406–415. doi: 10.1093/aje/kwg175.

47. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17(2): 179–188. doi: 10.1038/nm.2279.

48. Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 2011; 108(37): 15324–15329. doi: 10.1073/pnas.1100255108.

49. Vasseur P, Serres L, Jegou JF, et al. High-fat diet-induced IL-17A exacerbates psoriasiform dermatitis in a mouse model of steatohepatitis. Am J Pathol 2016; 186(9): 2292–2301. doi: 10.1016/j.ajpath.2016.05.012.

50. Lim HY, Rutkowski JM, Helft J, et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol 2009; 175(3): 1328–1337. doi: 10.2353/ajpath.2009.080963.

51. Arngrim N, Simonsen L, Holst JJ, et al. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: A possible link between obesity and local tissue inflammation? Int J Obes 2013; 37(5): 748–750. doi: 10.1038/ijo.2012.98.

52. Weiler M, Dixon JB. Differential transport function of lymphatic vessels in the rat tail model and the long-term effects of Indocyanine Green as assessed with near-infrared imaging. Front Physiol 2013; 4: 215. doi: 10.3389/fphys.2013.00215.

53. Blum KS, Karaman S, Proulx ST, et al. Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS One 2014; 9(4): e94713. doi: 10.1371/journal.pone.0094713.

54. Savetsky IL, Albano NJ, Cuzzone DA, et al. Lymphatic function regulates contact hypersensitivity dermatitis in obesity. J Invest Dermatol 2015; 135(11): 2742–2752. doi: 10.1038/jid.2015.283.

55. Field AE, Willett WC, Lissner L, et al. Dietary fat and weight gain among women in the Nurses’ Health Study. Obesity 2007; 15(4): 967–976. doi: 10.1038/oby.2007.616.

56. Talukdar S, Olefsky JM, Osborn O. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 2011; 32(9): 543–550. doi: 10.1016/j.tips.2011.04.004.

57. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: Pathophysiology and molecular mechanisms. Nutr Rev 2007; 65(6 Pt 2): S13–23. doi: 10.1301/nr.2007.jun.S13-S23.

58. Stelzner K, Herbert D, Popkova Y, et al. Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol 2016; 46(8): 2043–2053. doi: 10.1002/eji.201546263.

59. Kanemaru K, Matsuyuki A, Nakamura Y, et al. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice. Exp Dermatol 2015; 24(6): 436–442. doi: 10.1111/exd.12691.

60. Zhang Y, Li Q, Rao E, et al. Epidermal fatty acid binding protein promotes skin inflammation induced by high-fat diet. Immunity 2015; 42(5): 953–964. doi: 10.1016/j.immuni.2015.04.016.

61. Fitch E, Harper E, Skorcheva I, et al. Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 2007; 9(6): 461–467. doi: 10.1007/s11926-007-0075-1.

62. Pan Y, Tian T, Park CO, et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 2017; 543(7644): 252–256. doi: 10.1038/nature21379.

63. Clark RA. Resident memory T cells in human health and disease. Sci Transl Med 2015; 7(269): 269rv1. doi: 10.1126/scitranslmed.3010641.